8-K
filed May 28, 2026, 6:12 PM ET
ticker RANI
CIK 0001856725
other material
confidence high
sentiment neutral
materiality 0.10
Rani Therapeutics shareholders elect all 7 directors, ratify auditor at 2026 annual meeting
Rani Therapeutics Holdings, Inc.
- All director nominees elected with >57M votes each; Jean-Luc Butel had highest withhold (4,997,042).
- Ratification of CBIZ CPAs as auditor for FY2026 passed with 77,019,828 for, 332,645 against, 54,190 abstain.
- Record date had 99,812,515 Class A and 23,970,359 Class B shares outstanding, voting together as a single class.
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Rani Therapeutics Holdings, Inc. shareholders approved Election of director nominees to hold office until the 2027 annual meeting at the 2026-05-28 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-05-28
Exact text from the filing
The following is a summary of the matters voted on at the Annual Meeting based on the report of the voting results by the inspector of election.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Rani Therapeutics Holdings, Inc. shareholders approved Ratification of CBIZ CPAs P.C. as the independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-05-28 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-05-28
Exact text from the filing
The Company’s stockholders ratified the appointment of CBIZ CPAs P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026, as follows: For: 77,019,828 Against: 332,645 Abstain: 54,190
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.